PVP Compared to TURP for the Treatment of Benign Hyperplasia of the Prostate

Inclusion Criteria: * Male over the age of 40 * Diagnosed with symptomatic/obstructive symptoms secondary to BPH requiring surgical intervention as determined by their urologist * Experienced lower urinary tract symptoms (LUTS) secondary to BPH \> 3 months in duration * IPSS value of \> 12 * Peak urinary flow \< 15mL/sec on voided volume (minimum of 150 ml) * Prostate size, as measured by transrectal ultrasonography (TRUS), less than 100cc in volume * American Society of Anesthesiology (ASA) classification of physical status, class 1-3 * Able to read, understand, and sign the Informed Consent * Willing and able to comply with all follow-up requirements including multiple follow-up visits Exclusion Criteria: * Transvesically measured post-void residual volume \>400 mL * Currently in urinary retention * Chronic urinary retention * Medications impairing bladder contractibility * Uncorrectable bleeding disorders or long- term anticoagulation that cannot be stopped * Recent myocardial infarction or coronary artery stent placement * Any of the following diseases which appear to involve the bladder: myasthenia gravis, diabetes neuropathy, multiple sclerosis, spinal cord injury or Parkinson disease * Any patient with idiopathic atonic bladder * Major pelvic fractures that involved damage to the external urinary sphincter * Recently completed definitive radiation therapy for prostate cancer * Active localized or systemic infections; including active urinary tract infection * Active cystolithiasis, urethral strictures, bladder neck contracture, or acute prostatitis affecting bladder function * If patient's PSA value \> PSA age-adjusted normal value, patient needs to have a negative biopsy before participating in the study * Confirmed malignancy of the prostate * Bladder cancer treated with transurethral resection of bladder cancer (TURBT) within 12 months or any patients treated with Bacillius Calmette-Guerin (BCG) * Bilateral hydronephrosis on renal ultrasound * Urethral strictures or a residual volume \>400 ml * Immunocompromised * Previous TURP